Literature DB >> 31377719

Symmetrical drug-related intertriginous and flexural exanthema due to clindamycin.

Virginia Cabrera Hernandez1, Monica Gonzalez Afonso1, Ariel Callero Viera1, Lidon Martin-Fernandez Martin2.   

Abstract

Systemic drug exposure can produce a skin reaction consisting of symmetrical erythema involving the gluteal and intertriginous areas in the absence of systemic involvement. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) occurs after systemic exposure to a drug in which the patient was not previously sensitised, either in the first dose or after several doses. The mechanism of SDRIFE is unknown but is hypothesised to be the result of a delayed hypersensitivity response resulting in a cutaneous eruption some days after the exposure to the drug. The diagnosis should be clinical, based on the history and examination, but skin tests can also be performed to confirm sensitisation. But, as always, the gold-standard test is oral provocation. It is important to know this clinical entity to prevent re-exposure to the responsible allergen in the future. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  dermatology; skin; unwanted effects / adverse reactions

Mesh:

Substances:

Year:  2019        PMID: 31377719      PMCID: PMC6685379          DOI: 10.1136/bcr-2019-230077

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) associated with infliximab.

Authors:  Isil Bulur; Havva Ozge Keseroglu; Zeynep Nurhan Saracoglu; Müzeyyen Gönül
Journal:  J Dermatol Case Rep       Date:  2015-03-31

Review 2.  Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature.

Authors:  Laurence Nespoulous; Ioana Matei; Aurélie Charissoux; Christophe Bédane; Safaë Assikar
Journal:  Contact Dermatitis       Date:  2018-07-30       Impact factor: 6.600

Review 3.  Symmetrical drug-related intertriginous and flexural exanthema.

Authors:  Sze-Chin Tan; Justina W-L Tan
Journal:  Curr Opin Allergy Clin Immunol       Date:  2011-08

4.  SDRIFE (baboon syndrome) due to paracetamol: case report.

Authors:  Liborija Lugović-Mihić; Tomislav Duvančić; Majda Vučić; Mirna Situm; Maja Kolić; Josip Mihić
Journal:  Acta Dermatovenerol Croat       Date:  2013       Impact factor: 1.256

Review 5.  A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.

Authors:  Monika Winnicki; Neil H Shear
Journal:  Am J Clin Dermatol       Date:  2011-06-01       Impact factor: 7.403

Review 6.  First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?

Authors:  Gwenaëlle Allain-Veyrac; Anne Lebreton; Catherine Collonnier; Pascale Jolliet
Journal:  Am J Clin Dermatol       Date:  2011-06-01       Impact factor: 7.403

Review 7.  Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?

Authors:  P Häusermann; Th Harr; A J Bircher
Journal:  Contact Dermatitis       Date:  2004 Nov-Dec       Impact factor: 6.600

  7 in total
  2 in total

Review 1.  Immediate and Delayed Hypersensitivity Reactions to Antibiotics: Aminoglycosides, Clindamycin, Linezolid, and Metronidazole.

Authors:  Michelle Dilley; Bob Geng
Journal:  Clin Rev Allergy Immunol       Date:  2021-12-15       Impact factor: 10.817

2.  Remdesivir-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature.

Authors:  Johannes Heck; Dirk O Stichtenoth; Roland Mettin; Jörg Jöckel; Christoph Bickel; Benjamin Krichevsky
Journal:  Eur J Clin Pharmacol       Date:  2020-08-06       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.